{"id":45239,"date":"2022-06-20T06:01:47","date_gmt":"2022-06-20T04:01:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/"},"modified":"2022-06-20T06:01:47","modified_gmt":"2022-06-20T04:01:47","slug":"deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/","title":{"rendered":"Deenova\u00b4s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards"},"content":{"rendered":"<div>\n<p>MILAN&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=1&amp;md5=afe9fd81167cb94a3f7f2d985d013cbc\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a> today disclosed that it expanded its market dominance in France with another net new <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uniha.org&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=UniHA&amp;index=2&amp;md5=bd3108c34bcf0936d68412e61c0f99d6\" rel=\"nofollow noopener\" shape=\"rect\">UniHA<\/a> competitive award for its <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fd3-series%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=D3+ACCED&amp;index=3&amp;md5=457e77900e8dd6b7c133f3cbbc171a23\" rel=\"nofollow noopener\" shape=\"rect\">D3 ACCED<\/a> mechatronic solution at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.chmayotte.fr&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Centre+Hospitalier+de+Mayotte&amp;index=4&amp;md5=fa72a089a63b1f7d252646040ddb27b2\" rel=\"nofollow noopener\" shape=\"rect\">Centre Hospitalier de Mayotte<\/a> in French overseas departments. Additionally, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=5&amp;md5=1fd6f7657ed919d3d77cd475f71c8b13\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a> announced a new competitive tender win at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ghpso.fr&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=GHPSO+Creil+%26amp%3B+Senlis&amp;index=6&amp;md5=0ec447f850f93501fe7221b3ccca5e0d\" rel=\"nofollow noopener\" shape=\"rect\">GHPSO Creil &amp; Senlis<\/a> also for its market leading <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fd3-series%2Facced%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=D3+ACCED&amp;index=7&amp;md5=eb69303ce68ade644798d35c1b191e5a\" rel=\"nofollow noopener\" shape=\"rect\">D3 ACCED<\/a> mechatronic robot through its partnership with another premier hospital group, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.resah.fr&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=RESAH&amp;index=8&amp;md5=eac99e3e3ef6284aa4e2c8bfa74f8437\" rel=\"nofollow noopener\" shape=\"rect\">RESAH<\/a>. Separately, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=9&amp;md5=94c3c0ed7d2e75cff0ef9cba86ba2cda\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a> is pleased to simultaneously report additional add-on sales of its unique <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fd3-series%2Fastus%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=ASTUS+cabinets&amp;index=10&amp;md5=8caa888421e01dd412c7dca3836b5334\" rel=\"nofollow noopener\" shape=\"rect\">ASTUS cabinets<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fd3-series%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=D3+ACCED&amp;index=11&amp;md5=a69fbd0388992b7d5c72a415c466609b\" rel=\"nofollow noopener\" shape=\"rect\">D3 ACCED<\/a> to existing <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=12&amp;md5=8dae9cd7377553457bab5045e07df862\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a> customer <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.invalides.fr&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Institute+Nationale+des+Invalides&amp;index=13&amp;md5=9fb7d579c26199114964002002483545\" rel=\"nofollow noopener\" shape=\"rect\">Institute <span>Nationale des Invalides<\/span><\/a> in Paris, also through its <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uniha.org&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=UniHA&amp;index=14&amp;md5=aab55ae03c9c1a18c2d72207d75b3c8a\" rel=\"nofollow noopener\" shape=\"rect\">UniHA<\/a> partnership.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220619005038\/en\/839408\/5\/DEENOVA_GRIGIO.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220619005038\/en\/839408\/21\/DEENOVA_GRIGIO.jpg\"><\/a><\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Flo%252525C3%252525AFc-bessin-7342bb17a%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Lo%26iuml%3Bc+Bessin&amp;index=15&amp;md5=ac1b134fb6ad58e743a3a6c3214ebd6c\" rel=\"nofollow noopener\" shape=\"rect\">Lo\u00efc Bessin<\/a>, Managing Director of <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=16&amp;md5=c32c80e7904684153f4165ba31300e1f\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a> in France stated: \u201cBringing together net new business tender wins at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.chmayotte.fr&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Centre+Hospitalier+de+Mayotte&amp;index=17&amp;md5=357f5a4b56bac0c3cad488319b35f973\" rel=\"nofollow noopener\" shape=\"rect\">Centre Hospitalier de Mayotte<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ghpso.fr&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=GHPSO+Creil+%26amp%3B+Senlis&amp;index=18&amp;md5=a6635563daab1564497fc8e35f1ff93c\" rel=\"nofollow noopener\" shape=\"rect\">GHPSO Creil &amp; Senlis<\/a> for our <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fd3-series%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=D3+ACCED&amp;index=19&amp;md5=95193973d785a5f2fbac609f6874c0bb\" rel=\"nofollow noopener\" shape=\"rect\">D3 ACCED<\/a> mechatronic solutions, while at the same time earning the trust of additional sales to previous <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=20&amp;md5=b0ed134b9339fc49455590cd50d7dc1d\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a> <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fd3-series%2Fastus%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=ASTUS&amp;index=21&amp;md5=1b7c75fd1b8516cb8c1e5cd6d49246b2\" rel=\"nofollow noopener\" shape=\"rect\">ASTUS<\/a> customers such as <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.invalides.fr&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Institute+Nationale+des+Invalides&amp;index=22&amp;md5=7b79d1d15102bd131149ca9fbc5a5511\" rel=\"nofollow noopener\" shape=\"rect\">Institute Nationale des Invalides<\/a> is steady evidence of <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=23&amp;md5=f3a524e92245099ede83258f2899b861\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a> France unparalleled success in our industry, undoubtedly showing the market a high level of reliable customer satisfaction in France.\u201d\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fjaffuel%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Christophe+Jaffuel&amp;index=24&amp;md5=e66ba4f971226afc68bd91e9b9033d28\" rel=\"nofollow noopener\" shape=\"rect\">Christophe Jaffuel<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=25&amp;md5=f428243e58ad14496efb55952c8077ec\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a> Chief Commercial Officer, added: \u201cA new milestone for <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=26&amp;md5=d2ec4e83fe16ce34329ba7c30cbc5201\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a> is reached: expansion beyond the European continent, a great ongoing incentive for our sales teams. I am very appreciative for the important and yearly contribution that both <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uniha.org&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=UniHA&amp;index=27&amp;md5=726061ec52db998ec3eaa8bb3f594c2f\" rel=\"nofollow noopener\" shape=\"rect\">UniHA<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.resah.fr&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=RESAH&amp;index=28&amp;md5=93facbd5434ed9edab65f45e8e41474a\" rel=\"nofollow noopener\" shape=\"rect\">RESAH<\/a> ongoing multi-year tender awards means to <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=29&amp;md5=64b168668e1103fee7d3858784fd40e4\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a> in France and now beyond, renewing its past commitment to <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=30&amp;md5=8c383f1484fceb17c70b759a0bdc2141\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a> market-leading Unit-Dose solutions. I look forward to continuing the outstanding cooperation with <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uniha.org&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=UniHA&amp;index=31&amp;md5=e042730e407f1601e6e47a69d5ee6fcd\" rel=\"nofollow noopener\" shape=\"rect\">UniHA<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.resah.fr&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=RESAH&amp;index=32&amp;md5=9d1e382bf5b6289cc70ceb99420e8f81\" rel=\"nofollow noopener\" shape=\"rect\">RESAH<\/a> in the near future.\u201d\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.chmayotte.fr&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Centre+Hospitalier+de+Mayotte&amp;index=33&amp;md5=76d30f9b6e2024ec9ece7fbea71f3515\" rel=\"nofollow noopener\" shape=\"rect\">Centre Hospitalier de Mayotte<\/a>, a public health establishment with 543 beds, is the only hospital in the overseas <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FMayotte&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Department+of+Mayotte&amp;index=34&amp;md5=d7ef5816c030e07a37802f4978f94dac\" rel=\"nofollow noopener\" shape=\"rect\">Department of Mayotte<\/a>. It is located in the northern part of the Mozambique Channel in the Indian Ocean off the coast of Southeastern Africa. It provides both hospital care and out-patient care with 4 localized care and childbirth centers (North, Centre, South and Petite-Terre) of intermediate level, providing general consultations and a 24-hour medical service and 7 days a week.\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ghpso.fr&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=GHPSO+Creil+%26amp%3B+Senlis&amp;index=35&amp;md5=854e2f1faff51923aa554761c4600e99\" rel=\"nofollow noopener\" shape=\"rect\">GHPSO Creil &amp; Senlis<\/a>, located just 30 minutes from <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FCharles_de_Gaulle_Airport&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Paris+CDG+airport&amp;index=36&amp;md5=b2cc1d458914a6c466a88d5120f01070\" rel=\"nofollow noopener\" shape=\"rect\">Paris CDG airport<\/a>, offers a complete emergency service: Adult, Paediatric and Gyneco-obstetrics with 584 full hospital beds, 46 day hospitalization places, 21 haemodialysis stations, and on the other hand an offer in Follow-up and Rehabilitation Care (SSR) with 32 beds, in accommodation with 73 Long-Term Care Unit beds (USLD), 90 beds in an Accommodation Establishment for Dependent Elderly Persons (EHPAD) and 12 places in Alzheimer&#8217;s day centre, i.e. a total of 858 beds. The SMUR unit intervenes at the request of the SAMU de l\u2019Oise.\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.invalides.fr&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Institute+Nationale+des+Invalides&amp;index=37&amp;md5=8a256ffbfff0d7d3ce971485f717484e\" rel=\"nofollow noopener\" shape=\"rect\">Institute <span>Nationale des Invalides<\/span><\/a> is placed under the supervision of the French Government Ministry of Defense and Veterans Affairs. It is responsible for welcoming veterans who are victims of severe handicaps linked to war wounds. It includes three complementary centers: the Pensioners\u2019 Center, the Post-Traumatic Rehabilitation Center and the Center for Studies and Research on Equipment for the Handicapped. A total of 91 single rooms are fully equipped for patients in the Paris metropolitan area.\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uniha.org&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=UniHA&amp;index=38&amp;md5=e76389b668d63bad178fcaeaed8426f2\" rel=\"nofollow noopener\" shape=\"rect\">UniHA<\/a>, the Union of Hospitals for Purchasing, is a cooperative of French public hospital buyers created in 2005 by the hospital staff themselves (32 CHU and 20 CH). As of 2022, 1.065 hospitals have joined the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uniha.org&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=UniHA&amp;index=39&amp;md5=b8ccc1a62c55eb83402aae11fd26081a\" rel=\"nofollow noopener\" shape=\"rect\">UniHA<\/a> cooperative, with 115 GHT having conducted \u20ac 5.6 billion in group purchases in 2021. <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uniha.org&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=UniHA&amp;index=40&amp;md5=f7642371c26a2d82373aa1fb72fdb6da\" rel=\"nofollow noopener\" shape=\"rect\">UniHA<\/a> is one of the main European buyers in the field of health and one of the first national buyers, all sectors of activity combined. The essential challenge: to provide citizens with the best treatments available, to provide high-quality hospital services, and to preserve equal access to care.\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.resah.fr&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=RESAH&amp;index=41&amp;md5=49454608a6e4b5b87387514ead907952\" rel=\"nofollow noopener\" shape=\"rect\">RESAH<\/a> is a public interest group (GIP) whose objective is to support the pooling and professionalisation of purchases from the health sector, public and private non-profit. It was created in 2007 to support the pooling of hospital purchases for the Ile-de-France region, in collaboration with Achat Hopital.\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=42&amp;md5=a4def2b86dbfbbf1e661963dd2bfcecc\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a> is the undisputed leading supplier of combined <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FMechatronics&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=mechatronics+%28robotic+and+automation%29&amp;index=43&amp;md5=9ca44c6740db8c4d6bcc1e3619180f54\" rel=\"nofollow noopener\" shape=\"rect\">mechatronics (robotic and automation)<\/a> solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=44&amp;md5=4def5040444e1f91ba5f8d474eadd2bb\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a>\u2019s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers\u2019 growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume\/acuity and scarce medical staff. <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=45&amp;md5=5ccfa4f416866719398c3942bc1d5118\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a> guarantees the simplification of all processes related to the management of medications and implantable\/disposable medical devices with an expected cost savings range between 15% and 25%. Please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.deenova.com&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=www.deenova.com&amp;index=46&amp;md5=409b1337e6ffe7008a4b102add7dc6b7\" rel=\"nofollow noopener\" shape=\"rect\">www.deenova.com<\/a> for additional information on its market leading solutions.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nContacts at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.deenova.com%2Fen%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Deenova&amp;index=47&amp;md5=46c3b0e7810889af09c71631d52ecfaa\" rel=\"nofollow noopener\" shape=\"rect\">Deenova<\/a>:<br \/>\n<br \/><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Flo%252525C3%252525AFc-bessin-7342bb17a%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Lo%26iuml%3Bc+Bessin&amp;index=48&amp;md5=300146fc7d5645b4b243435fd804c845\" rel=\"nofollow noopener\" shape=\"rect\">Lo\u00efc Bessin<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fjaffuel%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Christophe+Jaffuel&amp;index=49&amp;md5=0a84784d1e4405d2e879d51c1f0e8970\" rel=\"nofollow noopener\" shape=\"rect\">Christophe Jaffuel<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fmartina-buccianti-3596a2a9%2F&amp;esheet=52754553&amp;newsitemid=20220619005038&amp;lan=en-US&amp;anchor=Martina+Buccianti&amp;index=50&amp;md5=032269f890765b3f115b75ac2bd04ad2\" rel=\"nofollow noopener\" shape=\"rect\">Martina Buccianti<\/a><br \/><a target=\"_blank\" href=\"mai&#108;&#116;&#111;&#58;&#x6d;&#x2e;&#x62;&#x75;&#x63;&#x63;&#x69;ant&#105;&#64;&#100;&#101;&#101;&#x6e;&#x6f;&#x76;&#x61;&#x2e;&#x63;om\" rel=\"nofollow noopener\" shape=\"rect\">m&#46;bucc&#105;&#97;&#110;&#116;&#105;&#64;&#100;&#x65;&#x65;&#x6e;&#x6f;&#x76;&#x61;&#x2e;&#x63;&#x6f;&#x6d;<\/a>, +39 0523 785311\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>MILAN&#8211;(BUSINESS WIRE)&#8211;Deenova today disclosed that it expanded its market dominance in France with another net new UniHA competitive award for its D3 ACCED mechatronic solution at Centre Hospitalier de Mayotte in French overseas departments. Additionally, Deenova announced a new competitive tender win at GHPSO Creil &amp; Senlis also for its market leading D3 ACCED mechatronic &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45239","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Deenova\u00b4s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Deenova\u00b4s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MILAN&#8211;(BUSINESS WIRE)&#8211;Deenova today disclosed that it expanded its market dominance in France with another net new UniHA competitive award for its D3 ACCED mechatronic solution at Centre Hospitalier de Mayotte in French overseas departments. Additionally, Deenova announced a new competitive tender win at GHPSO Creil &amp; Senlis also for its market leading D3 ACCED mechatronic ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-20T04:01:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220619005038\/en\/839408\/21\/DEENOVA_GRIGIO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Deenova\u00b4s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards\",\"datePublished\":\"2022-06-20T04:01:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\\\/\"},\"wordCount\":782,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220619005038\\\/en\\\/839408\\\/21\\\/DEENOVA_GRIGIO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\\\/\",\"name\":\"Deenova\u00b4s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220619005038\\\/en\\\/839408\\\/21\\\/DEENOVA_GRIGIO.jpg\",\"datePublished\":\"2022-06-20T04:01:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220619005038\\\/en\\\/839408\\\/21\\\/DEENOVA_GRIGIO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220619005038\\\/en\\\/839408\\\/21\\\/DEENOVA_GRIGIO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Deenova\u00b4s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Deenova\u00b4s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/","og_locale":"en_US","og_type":"article","og_title":"Deenova\u00b4s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards - Pharma Trend","og_description":"MILAN&#8211;(BUSINESS WIRE)&#8211;Deenova today disclosed that it expanded its market dominance in France with another net new UniHA competitive award for its D3 ACCED mechatronic solution at Centre Hospitalier de Mayotte in French overseas departments. Additionally, Deenova announced a new competitive tender win at GHPSO Creil &amp; Senlis also for its market leading D3 ACCED mechatronic ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-20T04:01:47+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220619005038\/en\/839408\/21\/DEENOVA_GRIGIO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Deenova\u00b4s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards","datePublished":"2022-06-20T04:01:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/"},"wordCount":782,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220619005038\/en\/839408\/21\/DEENOVA_GRIGIO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/","url":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/","name":"Deenova\u00b4s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220619005038\/en\/839408\/21\/DEENOVA_GRIGIO.jpg","datePublished":"2022-06-20T04:01:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220619005038\/en\/839408\/21\/DEENOVA_GRIGIO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220619005038\/en\/839408\/21\/DEENOVA_GRIGIO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/deenovas-france-remarkable-and-continued-success-extends-to-french-overseas-departments-winning-mayotte-ghpso-and-i-n-i-awards\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Deenova\u00b4s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45239"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45239\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}